Top results from Monash IVF Group Ltd: Is it a buy?

A year when pretty much everything went right for Monash IVF Group Ltd (ASX:MVF)

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Assisted reproductive services (ARS) provider Monash IVF Group Ltd (ASX: MVF) released a cracking financial report earlier today. Here are some of the highlights:

  • Revenue up 25.3% to $156.6 million (10.7% organic growth, 14.6% from acquisitions)
  • Net profit after tax (NPAT) up 34.6% to $28.8 million
  • Earnings-per-share (EPS) up 32.6% to 12.2 cents
  • Total IVF treatments up 12.9% to 17.9 million
  • Final fully franked dividend of 4.5 cents, 8.5 cents for the full year (3.6% yield) compared to 7 cents last year

It is always reassuring when a company delivers a clean set of statutory figures requiring no adjustments to understand underlying performance and that is what Monash provided today. The company's strong metrics extend beyond its profit and loss statement with return on equity (ROE) up 340 basis points to 19.3%, net debt down 10.6% to $86.5 million and cash flow from operations up 22.8% to $44.2 million.

Monash generates 96% of its revenue from Australia with the remainder sourced from Malaysia. Australian IVF treatments increased 12.4% outpacing the industry average of 8.2% in 2016. The industry growth rate was unusually high in 2016 and has averaged 4.1% historically so Monash cannot count on such favourable conditions every year.

The company has a 23.8% Australian market share with a particularly strong presence in Victoria and South Australia. The New South Wales region was boosted by a full year contribution from Sydney Ultrasound for Women, acquired in June 2015. This led to a 230.5% rise in the number of ultrasounds and 352.9% rise in the number of non-invasive prenatal tests performed by the group during the year. These services typically earn lower profit margins than the IVF business and Sydney Ultrasound for Women recorded earnings before interest, tax, depreciation and amortisation (EBITDA) margins of 22.8% compared to 31.7% for the group.

The Malaysian operation also experienced strong growth in terms of the number of treatments performed which rose 19.4% to 1,222. However, profit only grew by 4.3% to $2.4 million and was impacted by the introduction of GST in Malaysia and unfavourable currency moves.

Over the last five years Monash has increased revenue by 67.9%, but EBITDA has risen much faster at 132.7% illustrating the operating leverage at play in the business. This works both ways and I wonder whether ARS is the type of industry that will suffer during a recession as hard-up consumers put off expensive treatment until conditions improve. Still, based on its industry-leading success rates and large and growing market share I think that through the cycle Monash is likely to prosper.

It was interesting that despite a strong result today, Monash shares were down 3% in afternoon trading. The company is a leader in a growing niche market and looks reasonable value given it has a historical enterprise value-to-earnings ratio (EV/E) of 22x.

Motley Fool contributor Matt Brazier has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »